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Converting Solution Macromolecular
Thermodynamic Properties into The solution exchange rates of hydrogen atoms for
Gas-Phase Mass deuterium (HDX) in peptides, proteins, and nucleic acids
can be monitored using mass spectrometry [7–10]. Sol-Spectrometry Observations
vent-exposed amide hydrogen atoms will exchange with
deuterons, and each incorporated deuteron increases
the mass of the molecule by 1 Da, easily measured by
modern mass spectrometers. The measured differenceSolution dissociation constants and changes in free
between the theoretical maximum incorporation and theenergies associated with ligand binding to proteins
experimental result quantitatively reflects the protectionhave been measured in the gas phase using mass
from exchange. Various experimental strategies (quench-spectrometry.
ing, digestion, etc.) can be used with MS to measure
HDX rates for surface amide residues that exchangeCan a protein, nucleic acid, or other macromolecular
rapidly or for slowly exchanging amides sequestered incomplex retain a memory of its solution state as solvent
the core of a protein [11]. MS HDX studies have beenand counterions are removed in vacuo? At first glance,
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